Search research articles
Contact Us
Filters
Showing results (11-20 of 186) with videos related to
Page
of 19
Sort By:
Journal of the American Society of Nephrology : JASN
|
December 2, 2024
Protecting Podocytes in Glomerular Diseases Beyond Glucocorticoids
Rachel Njeim, Alessia Fornoni
Kidney International
|
May 12, 2016
Drug discovery in focal and segmental glomerulosclerosis
Nick Pullen, Alessia Fornoni
The Journal of Clinical Investigation
|
October 16, 2023
Adenine crosses the biomarker bridge: from 'omics to treatment in diabetic kidney disease
Yelena Drexler, Alessia Fornoni
Kidney360
|
September 30, 2022
The Many Lives of PCSK9: Therapeutic Implications
Jeffrey Pressly, Alessia Fornoni
BMC Medicine
|
December 14, 2006
Chronic kidney disease care delivered by US family medicine and internal medicine trainees: results from an online survey
Oliver Lenz, Alessia Fornoni
Clinical Journal of the American Society of Nephrology : CJASN
|
April 14, 2021
Could This Be Alport Syndrome?
Rachel Lennon, Alessia Fornoni
Kidney International
|
February 21, 2019
The elusive podocyte crossmatch for recurrent focal segmental glomerulosclerosis
George W Burke, Alessia Fornoni
The Journal of Pathology
|
October 3, 2020
Bedside to bench Alport syndrome research: are human urine-derived podocytes the answer?<sup>†</sup>
Jin-Ju Kim, Alessia Fornoni
Kidney Research and Clinical Practice
|
October 21, 2015
Nonimmunologic targets of immunosuppressive agents in podocytes
Tae-Hyun Yoo, Alessia Fornoni
Kidney International
|
February 22, 2026
Memories of Claudio Ponticelli
Gabriella Moroni, Richard Glassock, Alessia Fornoni
Page
of 19
Search research articles
Search
Showing results (11-20 of 186) with videos related to
Sort By:
Page
of 19
Journal of the American Society of Nephrology : JASN
|
December 2, 2024
Protecting Podocytes in Glomerular Diseases Beyond Glucocorticoids
Rachel Njeim, Alessia Fornoni
Kidney International
|
May 12, 2016
Drug discovery in focal and segmental glomerulosclerosis
Nick Pullen, Alessia Fornoni
The Journal of Clinical Investigation
|
October 16, 2023
Adenine crosses the biomarker bridge: from 'omics to treatment in diabetic kidney disease
Yelena Drexler, Alessia Fornoni
Kidney360
|
September 30, 2022
The Many Lives of PCSK9: Therapeutic Implications
Jeffrey Pressly, Alessia Fornoni
BMC Medicine
|
December 14, 2006
Chronic kidney disease care delivered by US family medicine and internal medicine trainees: results from an online survey
Oliver Lenz, Alessia Fornoni
Clinical Journal of the American Society of Nephrology : CJASN
|
April 14, 2021
Could This Be Alport Syndrome?
Rachel Lennon, Alessia Fornoni
Kidney International
|
February 21, 2019
The elusive podocyte crossmatch for recurrent focal segmental glomerulosclerosis
George W Burke, Alessia Fornoni
The Journal of Pathology
|
October 3, 2020
Bedside to bench Alport syndrome research: are human urine-derived podocytes the answer?<sup>†</sup>
Jin-Ju Kim, Alessia Fornoni
Kidney Research and Clinical Practice
|
October 21, 2015
Nonimmunologic targets of immunosuppressive agents in podocytes
Tae-Hyun Yoo, Alessia Fornoni
Kidney International
|
February 22, 2026
Memories of Claudio Ponticelli
Gabriella Moroni, Richard Glassock, Alessia Fornoni
Page
of 19